Lacerta Therapeutics
Alachua, US · Founded 2017 · Delaware corporation
Founders & leadership
Lacerta Therapeutics was founded in 2017 by Nicholas Muzyczka.
NM
Nicholas MuzyczkaFounder
JR
James RuscheNamed on SEC filing
JD
Joseph D. ReddyNamed on SEC filing
BB
Barry ByrneNamed on SEC filing
KW
Kenneth WarringtonNamed on SEC filing
SZ
Sergei ZolotukhinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 of 2 rounds · 2017–2018
▶$30MofferedAug 2018 · BiotechnologyRule 506(b)
▶$30MofferedAug 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James RuscheDirector
- Nicholas MuzyczkaDirector
- Joseph D. ReddyExecutive Officer, Director, Promoter
- Barry ByrneDirector, Promoter
- Kenneth WarringtonExecutive Officer, Promoter
- Sergei ZolotukhinDirector, Promoter
- Offering amount
- $30M
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$500KraisedAug 2018 · 6 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2018 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph D. ReddyExecutive Officer, Director, Promoter
- Kenneth WarringtonExecutive Officer, Promoter
- Nicholas MuzyczkaDirector
- Sergei ZolotukhinDirector, Promoter
- James RuscheDirector
- Barry ByrneDirector, Promoter
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Lacerta Therapeutics?
- Lacerta Therapeutics was founded by Nicholas Muzyczka in 2017.
- How much funding has Lacerta Therapeutics raised?
- Lacerta Therapeutics has disclosed $500K raised across 1 of its 2 known rounds.
- Where is Lacerta Therapeutics headquartered?
- Lacerta Therapeutics is headquartered in Alachua, US.